ImportRefusal LogoImportRefusal

Lgi Labs

⚠️ Moderate Risk

FEI: 3007477705 • Aurora, ON • CANADA

FEI

FEI Number

3007477705

📍

Location

Aurora, ON

🇨🇦

Country

CANADA
🏢

Address

219 Old Yonge St, , Aurora, ON, Canada

Moderate Risk

FDA Import Risk Assessment

33.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
4
Unique Violations
10/14/2011
Latest Refusal
4/15/2011
Earliest Refusal

Score Breakdown

Violation Severity
48.6×40%
Refusal Volume
28.8×30%
Recency
0.0×20%
Frequency
50.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

3364×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

711×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

Refusal History

DateProductViolationsDivision
10/14/2011
57AH02BOTULISM ANTITOXIN
2280DIRSEXMPT
472NO ENGLISH
71NO LICENSE
Detroit District Office (DET-DO)
4/15/2011
83KZICULTURE MEDIA, ENRICHED
336INCONSPICU
Detroit District Office (DET-DO)
4/15/2011
83KZICULTURE MEDIA, ENRICHED
336INCONSPICU
Detroit District Office (DET-DO)
4/15/2011
83KZICULTURE MEDIA, ENRICHED
336INCONSPICU
Detroit District Office (DET-DO)
4/15/2011
83KZICULTURE MEDIA, ENRICHED
336INCONSPICU
Detroit District Office (DET-DO)

Frequently Asked Questions

What is Lgi Labs's FDA import refusal history?

Lgi Labs (FEI: 3007477705) has 5 FDA import refusal record(s) in our database, spanning from 4/15/2011 to 10/14/2011.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Lgi Labs's FEI number is 3007477705.

What types of violations has Lgi Labs received?

Lgi Labs has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Lgi Labs come from?

All FDA import refusal data for Lgi Labs is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.